Icon selects AG Mednet to give trial sponsors zero-delay efficiency
AG Mednet has signed an OEM agreement with Icon Medical Imaging, a division of Icon, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into Icon’s imaging trial offerings.
AG Mednet provides the quality assurance and compliance technology necessary for clinical trials to operate with zero delay. The OEM partnership with AG Mednet provides Icon Medical Imaging with early insight into AG Mednet technology advancements for expanded capabilities, and will provide Icon’s imaging clients with a more efficient, compliant and cost-effective clinical trial system to expedite the clinical trial decision-making process.
AG Mednet’s technology and services will integrate with Icon’s MIRA and CTMS to provide sponsors and sites with the most advanced image data collection and delivery system in the market. AG Mednet supports all organizations in the clinical trial ecosystem: core labs, clinical research organizations, pharmaceutical companies and principal investigators.
“This OEM agreement is the culmination of years of collaboration and hard work between our companies,” said Abraham Gutman, president and CEO of AG Mednet. “Icon Medical Imaging has a far-reaching quality management vision that will reduce the burden on sites, increase trial efficiency and strengthen protocol compliance across all therapeutic areas.”